When was GENESIS Biomed founded?

GENESIS Biomed was founded in 2017.

Where is GENESIS Biomed's headquarters located?

GENESIS Biomed's headquarters is located in Barcelona (Spain).

How many companies has GENESIS Biomed invested in?

GENESIS Biomed has invested in 82 companies, including Abbott & Novartis.

Which companies has GENESIS Biomed invested in lately?

Ownmed Innovation & Affirma Biotech are the latest investments by GENESIS Biomed.

How many exits has GENESIS Biomed been involved in?

GENESIS Biomed's portfolio has seen 2 IPOs and 5 acquisitions.

GENESIS Biomed - 2026 Investor Profile, Portfolio, Team & Investment Trends

Q: How big is GENESIS Biomed's investment team?

GENESIS Biomed has a team of 8.

1. Abbott

Developer of medical devices, generic pharmaceuticals, and nutrition products. Its products are used by hospitals, laboratories, blood banks, and physicians. It is used to diagnose & monitor diseases such as HIV, hepatitis, cancer, heart failure, and metabolic disorders. In 2022, the company recorded annual revenues of $43.65B and a net profit of $6.93B

Key facts about Abbott

Founded Year: 1888
Location: Libertyville (United States)
Annual Revenue: $1B+ as on Dec 31, 2025
Stage: Public
Employee Count: 144,111 as on Apr 30, 2026
Investors: Digital Pharma Lab, Castle Investment Management and 12 Others
Latest Funding Round: Grant (prize money), Nov 17, 2021, $*****
Highlight: Public

2. Novartis

R&D focused on manufacturing of drugs for multiple therapeutic areas. The Company segments include Pharmaceuticals, which researches, develops, manufactures, distributes, and sells prescription medicines in the therapeutic areas, such as oncology, cardio-metabolic, immunology and dermatology, retina, respiratory, neuroscience, and established medicines; Alcon, which operates through over three franchises Surgical, Ophthalmic Pharmaceuticals and Vision Care, and Sandoz, which develops, manufactures and markets generic pharmaceutical products, follow-on biopharmaceutical products known as biosimilars, and other drug substances.

Key facts about Novartis

Founded Year: 1996
Location: Basel (Switzerland)
Annual Revenue: $0 - $1M as on Dec 31, 2017
Stage: Acquired
Employee Count: 83,811 as on Apr 30, 2026
Investors: Digital Pharma Lab, Atlas Venture and 9 Others
Latest Funding Round: Grant (prize money), Dec 01, 2018, $*****
Highlight: Acquired

3. Dr. Reddy's Laboratories

Multinational pharmaceutical company that develops and manufactures innovative and medicines to improve patient health. Its portfolio includes Active Pharmaceutical Ingredients, generics, branded generics, biosimilars, and over-the-counter pharmaceutical products. Company offers a wide range of pharmaceuticals across various therapeutic categories, including gastrointestinal, cardiovascular, pain management, oncology, anti-infectives, pediatrics, and dermatology.

Key facts about Dr. Reddy's Laboratories

Founded Year: 1984
Location: Hyderabad (India)
Annual Revenue: ₹1,000+ Cr as on Mar 31, 2026
Stage: Public
Employee Count: 27,535 as on Mar 31, 2026
Investors: ICICI Venture, Life Insurance Corporation of India and 5 Others
Latest Funding Round: Post IPO, Feb 26, 2025, $*****
Highlight: Public

4. Imec

Key facts about Imec

Founded Year: 1984
Location: Leuven (Belgium)
Stage: Funding Raised
Employee Count: 4,889 as on Jun 30, 2026
Investors: Samsung Catalyst Fund, Flanders and 6 Others
Latest Funding Round: Grant (prize money), May 14, 2025, $*****
Highlight: Editors' Pick

5. CSIC

Provider of scientific research and technological development. This agency conducts research across various scientific areas, including societal, life, and material sciences. It supports researchers through funding, infrastructure, and training programs. The agency also facilitates technology transfer and innovation, connecting its research with businesses and society. It engages in science communication and education initiatives to promote scientific literacy. The agency's activities aim to advance knowledge and contribute to societal progress.

Key facts about CSIC

Founded Year: 1939
Location: Madrid (Spain)
Stage: Funding Raised
Employee Count: 135 as on Jun 30, 2026
Investors: GENESIS Biomed, Europa and 2 Others
Latest Funding Round: Grant (prize money), May 07, 2025, $*****

View the full list of portfolio companies

GENESIS Biomed has invested in 82 companies over the last 7 years, with an average of 1 new investment annually in the last 5 years. Its most recent first time investment was in Ownmed Innovation.

Here are GENESIS Biomed's Year-on-Year Investment Trends:

Year	No. of Investments
Year	1^st Round	Follow-on	Total
2026 (YTD)	0	0	0
2025	0	0	0
2024	2	0	2
2023	0	0	0
2022	0	0	0
2021	1	0	1
2020	0	0	0
2019	1	0	1

View all investments by GENESIS Biomed

GENESIS Biomed has made 4 investments in Seed stage with an average round size of $1.9M.

View all investments by GENESIS Biomed

GENESIS Biomed has a diverse portfolio, with companies operating in the Life Sciences, Healthcare, High Tech and Sustainability Tech. Notably, it has invested in 39 Enterprise (B2B) companies, 34 Tech companies, 10 Tech hardware companies and at least 9 companies focusing on Software.

Here are GENESIS Biomed's investments by sector:

Sector	No. of Investments
Life Sciences	3
Healthcare	1
High Tech	1
Sustainability Tech	1

Note: We have considered here, only first round of investments

View all investments by GENESIS Biomed

GENESIS Biomed has made most investments in Spain (4).

View all investments by GENESIS Biomed

GENESIS Biomed has not made any investment in 2026 so far.

Here are the most recent investments by GENESIS Biomed:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
May 23, 2024	Ownmed Innovation	Spain	Seed	8926	-
Feb 01, 2024	Affirma Biotech	Spain	Seed	2539	Nara Capital [+5]
Jul 07, 2021	Corify	Spain	Seed	6309	CDTI [+3]
Mar 18, 2019	ADmit Therapeutics	Spain	Seed	6743	Bstartup Banco Sabadell [+2]

See more recent investments made by GENESIS Biomed

2 of GENESIS Biomed's portfolio companies have become public. Dr. Reddy's Laboratories got listed on the Bombay Stock Exchange (BSE), in Aug 1986 and Abbott got listed on the New York Stock Exchange (NYSE).

Here are GENESIS Biomed's portfolio companies that went public:

Filter this list

Company	IPO Date	First Invested on	First Round of Investment	Round Size
Dr. Reddy's Laboratories	Aug 28, 1986	-	-	1777
Abbott	Jan 06, 1978	-	-	8825

View more details about public companies in GENESIS Biomed's portfolio

5 companies from GENESIS Biomed's portfolio have been acquired. The most recent acquisition was Atos in May 2026 by Semantix AI for $*****.

Here are GENESIS Biomed's portfolio companies that got acquired most recently:

Filter this list

Company	Acquisition Date	First Invested on	First Round of Investment	Round Size
Atos	May 07, 2026	-	-	8147
Novartis	Feb 21, 2026	-	-	8389
HT Médica	Nov 30, 2023	-	-	6829
ABAC Therapeutics	Nov 20, 2019	-	-	4785
EchoSens	Mar 09, 2018	-	-	1495

View all acquired companies in GENESIS Biomed's portfolio

GENESIS Biomed has a team of 8 members including 1 Partner and 2 Principals located in Spain. GENESIS Biomed's team does not sit on the board of any company as of now.

Here is a list of all team members in GENESIS Biomed:

Name	Designation	Location	Board Memberships	Contact Details
Natalia de la Figuera	Partner	Barcelona	-	2 Emails
Jordi Ortiz Sagrista	Principal	Barcelona	-	1 Email
Mireia Samitier Marti	Principal	Spain	-	1 Email

View team details of GENESIS Biomed

Over the past 7 years, 22 investors have co-invested in GENESIS Biomed's portfolio companies. This includes funds and angels.

Invested before GENESIS Biomed: EIT Health, Laboratorio Reig Jofre and 2 others have invested in rounds before GENESIS Biomed. There is 1 company where EIT Health has invested before GENESIS Biomed and 1 company where Laboratorio Reig Jofre has invested before GENESIS Biomed.
Top Co-investors of GENESIS Biomed: 11 investors entered a company along with GENESIS Biomed. These include investors like Bstartup Banco Sabadell (1 company).
Invested after GENESIS Biomed: A total of 7 investors have invested in GENESIS Biomed's portfolio after their investments. Top Investors include Alzheimer's Drug Discovery (1 company) and Europa (1 company).